Clindamycin Phosphate Injection, Solution
Product Images NDC 0338-3814

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Clindamycin Phosphate (NDC 0338-3814). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Representative Container Ndc 0338-3814-50 Panel 2 Of 2 (Image 13)

Packaging label for Clindamycin phosphate intravenous injection solution by Baxter Healthcare Company. The label contains a barcode with the text 'BAR CODE POSITION ONLY' and the numeric code '30383814500' on a pink background. No dosage strength or package size is visible.*

FDA Label Image

Clindamycin In 5% Dextrose Structural Formula (Image 01)

Chemical structure of clindamycin phosphate, depicting its molecular components including the phosphate group, methylthio substituent, and various carbon and nitrogen atoms characteristic of the clindamycin molecule.*

FDA Label Image

Representative Container Label Ndc 0338-3410-50 Panel 1 Of 2 (Image 02)

Label for Clindamycin Injection USP in 5% Dextrose, 300 mg per 50 mL solution for intravenous use. The label indicates a 50 mL single dose container, sterile and nonpyrogenic, from Baxter Healthcare Company. It includes storage instructions, cautions against rapid injection and use in series connections, and specifies USP-grade ingredients.*

FDA Label Image

Representative Container Label Ndc 0338-3410-50 Panel 2 Of 2 (Image 03)

The image shows a pink label with the text 'BAR CODE POSITION ONLY' and a numeric code '303838410504'. It appears to be a placeholder label for barcode placement on a pharmaceutical product.*

FDA Label Image

Representative Carton Ndc 0338-3410-24 Panel 1 Of 2 (Image 04)

Clindamycin phosphate injection solution in 5% Dextrose, 300 mg per 50 mL (6 mg/mL), presented in single dose containers. The label indicates storage instructions at controlled room temperature (20° to 25°C) with a caution to avoid temperatures above 30°C. Manufactured by Baxter Healthcare Corporation, Deerfield, IL, USA. The container is PL 2501 Plastic, branded under Baxter and Galaxy trademarks.*

FDA Label Image

Representative Carton Ndc 0338-3410-24 Panel 2 Of 2 (Image 05)

A text panel for Clindamycin phosphate injection, 300 mg/50 mL strength, for intravenous use. It includes dosing instructions, composition details with clindamycin phosphate and other ingredients, cautions against use in series connections, and advises checking for leaks and solution clarity. The label indicates it is sterile and nonpyrogenic, labeled by Baxter Healthcare Company.*

FDA Label Image

Representative Serialized Label 0338-3410-24 (Image 06)

Label for Clindamycin Injection USP in 5% Dextrose, 300 mg/50 mL intravenous injection solution by Baxter Healthcare Company. Displays storage instructions at 20°C to 25°C, lot number, expiration date placeholders, serial number, and NDC 0338-3410-24.*

FDA Label Image

Representative Container Ndc 0338-3612-50 Panel 1 Of 2 (Image 07)

Clindamycin Injection USP 600 mg per 50 mL in 5% Dextrose is an intravenous injection solution supplied in a 50 mL single dose container. The label indicates the product is sterile, nonpyrogenic, and contains Clindamycin phosphate equivalent to 600 mg per 50 mL. It is labeled for intravenous use only, with storage instructions and manufacturer details from Baxter Healthcare Company.*

FDA Label Image

Representative Container Ndc 0338-3612-50 Panel 2 Of 2 (Image 08)

The image shows a label with a pink background containing a black square framing the text 'BAR CODE POSITION ONLY' and the digits '303383612502', indicating a placeholder for barcode placement. The label does not display any product-specific branding or dosage information.*

FDA Label Image

Representative Carton Ndc 0338-3612-24 Panel 1 Of 2 (Image 09)

Clindamycin Injection USP in 5% Dextrose 600 mg per 50 mL (12 mg/mL) intravenous solution. The label specifies storage instructions at 20° to 25°C (68° to 77°F) and avoidance of temperatures above 30°C. Manufactured by Baxter Healthcare Corporation, Deerfield, IL, USA, the product contains twelve 50 mL single-dose containers.*

FDA Label Image

Representative Carton Ndc 0338-3612-24 Panel 2 Of 2 (Image 10)

Drug information text panel for Clindamycin phosphate injection, solution, 600 mg/50 mL concentration. The label specifies intravenous use with directions against rapid injection or push, lists active ingredient content per 50 mL, inactive ingredients, dosage reference, and cautions about medication use and connection types. Label also states sterile, nonpyrogenic conditions and bar code placement instructions.*

FDA Label Image

Representative Serialized Label 0338-3612-24 (Image 11)

Two identical labels for Clindamycin Injection USP in 5% Dextrose, 600 mg per 50 mL intravenous solution. Each label shows the product name, concentration, NDC code 0338-3612-24, storage instructions (store at 20° to 25°C, avoid above 30°C), and is labeled by Baxter Healthcare Corporation, Deerfield, IL. Each label includes placeholders for lot number, expiration date, and serial number.*

FDA Label Image

Representative Container Ndc 0338-3814-50 Panel 1 Of 2 (Image 12)

Drug facts panel for Clindamycin Injection USP in 5% Dextrose, 900 mg per 50 mL. It is a sterile, nonpyrogenic 50 mL single-dose container labeled for intravenous use only. The panel provides active ingredient details, dosage instructions, storage conditions, and cautionary statements. Manufactured by Baxter Healthcare Corporation.*

FDA Label Image

Representative Carton Ndc 0338-3814-24 Panel 1 Of 2 (Image 14)

Clindamycin Injection USP in 5% Dextrose, 900 mg per 50 mL (18 mg/mL), solution for intravenous injection. Packaging includes 12 single-dose containers of 50 mL each. Labeler is Baxter Healthcare Corporation, made in the USA. The label instructs storage at 20 to 25°C (68 to 77°F) and warns to avoid temperatures above 30°C.*

FDA Label Image

Representative Carton Ndc 0338-3814-24 Panel 2 Of 2 (Image 15)

Clindamycin phosphate injection, solution for intravenous use, labeled with the NDC 0338-3814-24 and code 2G3454. The label states the product contains 900 mg clindamycin per 50 mL. It is sterile, nonpyrogenic, and for intravenous use only. The label includes usage cautions, dosing references, and formulation details specifying clindamycin phosphate with excipients and pH adjustment agents. The labeler is Baxter Healthcare Company.*

FDA Label Image

Representative Serialized Label 0338-3814-24 (Image 16)

Label for Clindamycin Injection USP 900 mg/50 mL in 5% Dextrose solution. The label displays storage instructions (20°C to 25°C, Avoid temperatures above 30°C), lot number, expiration date, and serial number fields. The product is labeled Rx Only and manufactured by Baxter Healthcare Corporation, Deerfield, IL, USA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.